/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
Valued at a market cap of $9.4 billion, DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure. The Denver, Colorado-based company also offers outpatient, hospital inpatient, and home-based hemodialysis services, as well as clinical laboratory services.
Companies worth $2 billion or more are typically classified as “mid-cap stocks,” and DaVita fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical care facilities industry. The company’s strength lies in its extensive network of dialysis centers across the U.S., which allows it to serve a large and growing population of patients with chronic kidney disease.